Switzerland· 67588009
Atomoxetin-Mepha
A atomoxetine product containing atomoxetinum, registered in Switzerland and dispensed under Swissmedic category A, on the national reimbursement list. The same ATC class is registered in 17 of our 19 countries.
Checked against BAG Spezialitätenliste (Switzerland) on
Informational only — not a medical device.
Where it is registered
Atomoxetine is registered in 17 of 19 countries.
Countries holding a registration under ATC N06BA09 (atomoxetine), each read from that country’s own register.
- This record: Switzerland, from BAG Spezialitätenliste (Switzerland)
- 10 of them publish a price we can compare per daily dose
Atomoxetine · ATC N06BA09
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of atomoxetine costs, country by country.
Normalised to the WHO defined daily dose (80 mg), the median price runs from $1.05 in United States to $9.70 in Switzerland — a ×9.2 gap.
- Switzerland: $9.70 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Atomoxetine · price per daily dose (80 mg)
USD · FX 28 Sept 2026
- CH Switzerland$9.70
- ES Spain$2.37
- US United States$1.05 (acquisition cost)
The record
At a glance
BAG Spezialitätenliste (Switzerland)- Active substance
- atomoxetinum
- Manufacturer
- —
- Country
- Switzerland (CH)
- ATC code
- N06BA09
- ATC class
- Atomoxetine
- Defined daily dose
- 80 mg, O
- Swissmedic category
- A
- Reimbursed
- Yes
- Source register
- BAG Spezialitätenliste (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- gtin7680675880096Blist 28 StkCHF 61
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
275 interactions on record for atomoxetine.
Graded by severity as the source publishes them — 50 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Atomoxetine · interactions on record
275 records
- 50 severe
- 166 moderate
- 4 minor
- 54 info
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- PapaverinC04AX38severe
1 more interaction with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Atomoxetine in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaATOMINEXZentiva, k.s., Praha
- United StatesatomoxetineNorthstar Rx LLC
- United KingdomATOMAID 80mg capsulesDr Reddy's Laboratories (UK) Ltd
- SwedenAtomoxetin Actavis 80 mg Kapsel, hårdActavis Group PTC ehf.
- SpainATAMAX 80 MG CAPSULAS DURAS EFGLaboratorios Rubio S.A.
- NorwayAtomoxe 1a pharma1 A Pharma
- NetherlandsAtofab 80 mg harde capsulesG.L. Pharma GmbH
- CanadaAPO-ATOMOXETINEAPOTEX INC
Authorised across Europe · EMA
The same active substance is authorised in 25 EEA countries. Names it is sold under:
- Austria · Atofab, Atomoxetin Amarox
- Belgium · Strattera
- Bulgaria · Atofab
- Cyprus · Strattera
- Czechia · Atofab, Atominex
- Germany · Agakalin, Atama
- Denmark · Atomoxetin Amarox, Atomoxetin Glenmark
- Estonia · Atominex
- Spain · Atamax, Atomoxetina Aurovitas
- Finland · Atomoxetin Orion, Atomoxetine Accord
- United Kingdom (Northern Ireland) · Atomaid, Atomoxetine
- Greece · Atama
- Croatia · Attoxem
- Hungary · Atomoxetin Amarox, Bitinex
- Ireland · Atomoxetine Accord, Atomoxetine Azure
- Iceland · Atomoxetin Actavis, Atomoxetin Medical Valley
- Malta · Atomoxetina Generis, Atomoxetine Aurobindo
- Netherlands · Atofab, Atomoxetine Accord
- Norway · Atomoxetin Orion, Atomoxetine Accord
- Poland · Atomoksetyna Medice, Auroxetyn
- Portugal · Atomoxetina Generis, Atomoxetina Macleods
- Romania · Atofab, Atomoxetin Accord
- Sweden · Atomoxetin Actavis, Atomoxetin Amarox
- Slovenia · Atomoksetin Accord, Strattera
- Slovakia · Atofab, Atominex
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of BAG Spezialitätenliste (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e8f7f5a8-99a5-46ca-9b6b-23b4b6f1b81a GET /v1/drugs/e8f7f5a8-99a5-46ca-9b6b-23b4b6f1b81a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unit": null,
"strength": "atomoxetinum 80 mg",
"valid_from": "2021-02-01",
"limitations": "[{\"description\":\"Nur zur second-line Behandlung des ADHS, d.h. bei Unverträglichkeit, Kontraindikation oder nicht Ansprechen von Methylphenidat bei Kindern ab 6 Jahren und Jugendlichen im Rahmen eines umfassenden Behandlungsprogramms. Wenn Patienten über 1 Jahr hinaus behandelt werden, so hat eine erneute Überprüfung der Behandlungsnotwendigkeit durch einen Arzt zu erfolgen, der über das notwendige Fachwissen in der Behandlung des ADHS verfügt.<br>\\n<br>\",\"costApproval\":null,\"indication\":null,\"isNew\":false,\"limitationCode\":null,\"points\":null,\"priceModel\":null,\"title\":null,\"validFrom\":\"2021-02-01\",\"validTo\":null},{\"description\":\"Kinder und Jugendliche<br>\\nNur zur second-line Behandlung des ADHS, d.h. bei Unverträglichkeit, Kontraindikation oder nicht Ansprechen von Methylphenidat bei Kindern ab 6 Jahren und Jugendlichen im Rahmen einer therapeutischen Gesamtstrategie. Wenn Patienten über 1 Jahr hinaus behandelt werden, so hat eine erneute Überprüfung der Behandlungsnotwendigkeit durch einen Arzt zu erfolgen, der über das notwendige Fachwissen in der Behandlung des ADHS verfügt.<br>\\n<br>\\nErwachsene<br>\\nNur zur second-line Behandlung des ADHS bei Erwachsenen bis 50 Jahren mit einer seit dem Kindesalter fortbestehenden ADHS im Rahmen einer therapeutischen Gesamtstrategie, für die eine Behandlung mit Stimulanzien, wie methylphenidathaltigen Arzneimitteln, aufgrund von begleitenden psychiatrischen oder Sucht-Erkrankungen nicht in Frage kommt oder die nicht ausreichend auf methylphenidathaltige Arzneimittel angesprochen haben. Die Diagnosestellung und initiale Verordnung hat durch einen Facharzt der Psychiatrie und Psychotherapie mit Spezialisierung auf Behandlung des ADHS zu erfolgen. Die Diagnose hat anhand der Kriterien resp. Richtlinien der Fachinformation zu erfolgen. Wenn Patienten über 1 Jahr hinaus behandelt werden, so hat eine erneute Überprüfung der Behandlungsnotwendigkeit durch einen Facharzt der Psychiatrie und Psychotherapie mit Spezialisierung auf Behandlung des ADHS zu erfolgen.<br>\\n<br>\",\"costApproval\":null,\"indication\":null,\"isNew\":false,\"limitationCode\":null,\"points\":null,\"priceModel\":null,\"title\":null,\"validFrom\":\"2022-01-01\",\"validTo\":null}]",
"galenic_form": "Kaps 80 mg",
"therapeutic_area": null,
"sl_inclusion_date": "2021-02-01",
"self_retention_pct": 10
}See everything about atomoxetine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.